These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 35140049)
1. Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma. Rosiello G; Larcher A; Fallara G; Giancristofaro C; Martini A; Re C; Cei F; Musso G; Tian Z; Karakiewicz PI; Mottrie A; Bertini R; Salonia A; Necchi A; Raggi D; Briganti A; Montorsi F; Capitanio U Urol Oncol; 2022 Jun; 40(6):271.e19-271.e27. PubMed ID: 35140049 [TBL] [Abstract][Full Text] [Related]
2. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy. Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350 [TBL] [Abstract][Full Text] [Related]
3. The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort. Klatte T; Gallagher KM; Afferi L; Volpe A; Kroeger N; Ribback S; McNeill A; Riddick ACP; Armitage JN; 'Aho TF; Eisen T; Fife K; Bex A; Pantuck AJ; Stewart GD BMC Med; 2019 Oct; 17(1):182. PubMed ID: 31578141 [TBL] [Abstract][Full Text] [Related]
4. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ; BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519 [TBL] [Abstract][Full Text] [Related]
6. Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality-free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients. Piccinelli ML; Barletta F; Tappero S; Cano Garcia C; Incesu RB; Morra S; Scheipner L; Tian Z; Luzzago S; Mistretta FA; Ferro M; Saad F; Shariat SF; Ahyai S; Longo N; Tilki D; Chun FKH; Terrone C; Briganti A; de Cobelli O; Musi G; Karakiewicz PI Eur Urol Focus; 2023 Sep; 9(5):799-806. PubMed ID: 37024421 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma. Tan MH; Kanesvaran R; Li H; Tan HL; Tan PH; Wong CF; Chia KS; Teh BT; Yuen J; Chong TW Urology; 2010 Jun; 75(6):1365-1370; 1370.e1-3. PubMed ID: 20022084 [TBL] [Abstract][Full Text] [Related]
8. External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer. Oza B; Eisen T; Frangou E; Stewart GD; Bex A; Ritchie AWS; Kaplan R; Smith B; Davis ID; Stockler MR; Albiges L; Escudier B; Larkin J; Joniau S; Hancock B; Hermann GG; Bellmunt J; Parmar MKB; Royston P; Meade A J Clin Oncol; 2022 Jun; 40(16):1772-1782. PubMed ID: 35213214 [TBL] [Abstract][Full Text] [Related]
9. External validation of the VENUSS prognostic model to predict recurrence after surgery in non-metastatic papillary renal cell carcinoma: A multi-institutional analysis. Erdem S; Capitanio U; Campi R; Mir MC; Roussel E; Pavan N; Kara O; Klatte T; Kriegmair MC; Degirmenci E; Aydin R; Minervini A; Serni S; Berni A; Rebez G; Ozcan F; Urol Oncol; 2022 May; 40(5):198.e9-198.e17. PubMed ID: 35172939 [TBL] [Abstract][Full Text] [Related]
10. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Beck SD; Patel MI; Snyder ME; Kattan MW; Motzer RJ; Reuter VE; Russo P Ann Surg Oncol; 2004 Jan; 11(1):71-7. PubMed ID: 14699037 [TBL] [Abstract][Full Text] [Related]
12. GRade, Age, Nodes, and Tumor (GRANT) compared with Leibovich score to predict survival in localized renal cell carcinoma: A nationwide study. Juul S; Donskov F; Clark PE; Lund L; Azawi NH Int J Urol; 2022 Jul; 29(7):641-645. PubMed ID: 35362146 [TBL] [Abstract][Full Text] [Related]
13. 2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race. Schmeusser BN; Patil DH; Nicaise EH; Armas-Phan M; Nabavizadeh R; Narayan VM; Joshi SS; Ogan K; Osunkoya AO; Bilen MA; Master VA Cancer; 2024 Feb; 130(3):453-466. PubMed ID: 37803521 [TBL] [Abstract][Full Text] [Related]
14. Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma. Rosiello G; Palumbo C; Knipper S; Pecoraro A; Luzzago S; Tian Z; Larcher A; Capitanio U; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI Urol Oncol; 2020 May; 38(5):537-544. PubMed ID: 32122729 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1-4 cm renal cell carcinomas. Rosiello G; Pecoraro A; Luzzago S; Deuker M; Stolzenbach LF; Tian Z; Larcher A; Capitanio U; Montorsi F; Shariat SF; Kapoor A; Saad F; Briganti A; Karakiewicz PI Cancer Causes Control; 2021 Feb; 32(2):119-126. PubMed ID: 33169306 [TBL] [Abstract][Full Text] [Related]
16. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. Capitanio U; Cloutier V; Zini L; Isbarn H; Jeldres C; Shariat SF; Perrotte P; Antebi E; Patard JJ; Montorsi F; Karakiewicz PI BJU Int; 2009 Jun; 103(11):1496-500. PubMed ID: 19076149 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma. Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774 [TBL] [Abstract][Full Text] [Related]
18. Predicting recurrence and survival in patients with non-metastatic renal-cell carcinoma after nephrectomy: a prospective population-based study with multicenter validation. Wang Y; Xuan Y; Su B; Gao Y; Fan Y; Huang Q; Zhang P; Gu L; Niu S; Shen D; Li X; Wang B; Zhu Q; Ouyang Z; Xie J; Ma X Int J Surg; 2024 Feb; 110(2):820-831. PubMed ID: 38016139 [TBL] [Abstract][Full Text] [Related]
19. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study. Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599 [TBL] [Abstract][Full Text] [Related]
20. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Cheville JC; Lohse CM; Zincke H; Weaver AL; Blute ML Am J Surg Pathol; 2003 May; 27(5):612-24. PubMed ID: 12717246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]